RxDoctor Payments Data

Saif Mashaqi, MD

Sleep Medicine · Tuscon, AZNPI 1043424633

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 52.2% of the total. That places this record below the midpoint for sleep medicine clinicians in AZ, where the typical reported total is $2,490.

$420in general payments, 2019–2025

Across 6 payments — averaging $69.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Respicardia, Inc.$219
  • Itamar Medical Inc$119
  • Livanova USA, Inc.$41
  • Inspire Medical Systems, Inc.$41
$437,892in research payments, 2019–2025

Across 182 payments — averaging $2406.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$437K
  • Jazz Pharmaceuticals Inc.$598

What the payments were for

  • Food & beverage$420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$420 in reported general payments places this provider in the 20th percentile of 47 sleep medicine providers in Arizona.

See all sleep medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$38,171
Medicare patients
296
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QuviviqDaridorexant Hcl53$31,603
BelsomraSuvorexant43$20,801
DayvigoLemborexant25$8,505
Doxepin Hcl42$5,302
Ramelteon17$1,743
Prazosin Hcl31$701
Modafinil15$623
Gabapentin81$544
Ropinirole Hcl40$522
Pramipexole DihydrochloridePramipexole Di-Hcl38$485
Eszopiclone25$241
Trazodone Hcl35$160
Zolpidem Tartrate14$111
Pregabalin13$85

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Tuscon

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →